Not independent
Tenure on this board
10.2 yrs
Also a director at
Chemours Co (CC)
3 nominees · 3 ballot items.
Elect three directors; advisory approval of executive compensation (say-on-pay); ratify Deloitte & Touche LLP as independent registered public accounting firm.
Elect three directors — Sean D. Keohane, Raffiq Nathoo, and Thierry Vanlancker — to the Board for terms expiring in 2029.
Non-binding advisory vote to approve the compensation of the named executive officers as disclosed in the proxy statement.
This non-binding advisory proposal asks stockholders to approve the compensation of Cabot’s named executive officers as disclosed in the proxy statement. Management seeks shareholder endorsement to validate the structure and outcomes of its pay programs, which emphasize a high proportion of at-risk pay tied to both short- and long-term financial metrics (STI and LTI programs with PSUs, options, and TSUs). The CD&A explains that fiscal 2025 payouts reflected company performance (90% corporate STI payout and varying individual performance multipliers) and long-term incentives aligned with adjusted EPS and adjusted RONA goals. The Board recommends a FOR vote, citing strong alignment of pay with performance, robust governance features (clawback policy, caps, multi-year vesting and stock ownership guidelines), and recent favorable shareholder say-on-pay results (98% support in 2025). Opponents would point to the advisory nature of the vote and any concerns about absolute levels of pay or specific elements like relocation/tax-equalization benefits for international assignees. The Board intends to consider shareholder feedback on pay but believes current programs appropriately incentivize management to execute strategy and create shareholder value, and asks shareholders to approve the disclosed compensation.
Ratify the Audit Committee’s appointment of Deloitte & Touche LLP as Cabot’s independent registered public accounting firm for fiscal year ending September 30, 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 7.89% | 4,075,499 | $307M |
| 2 | EARNEST PARTNERS LLC | 6.12% | 3,158,617 | $238M |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.05% | 3,121,342 | $235M |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 5.05% | 2,604,828 | $196M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.50% | 2,324,307 | $175M |
| 6 | AMERICAN CENTURY COMPANIES INC | 4.33% | 2,237,491 | $169M |
| 7 | FULLER THALER ASSET MANAGEMENT, INC. | 3.97% | 2,048,260 | $154M |
| 8 | STATE STREET CORP | 3.93% | 2,027,336 | $153M |
| 9 | BlackRock, Inc. | 3.27% | 1,688,009 | $127M |
| 10 | DIMENSIONAL FUND ADVISORS LP | 3.14% | 1,620,831 | $122M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.